NCT01839981View on ClinicalTrials.gov

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic CancerStage IV Pancreatic Cancer
Interventions
DRUG

6,8-bis(benzylthio)octanoic acid

Given IV

Trial Locations (1)

27157

Comprehensive Cancer Center of Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT01839981 - CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter